pancreatic cancer
Seqster, National Pancreas Foundation Partner on Pancreatic Disease Registry
Seqster will aggregate data from DNA tests and other sources to inform and assist research into new treatments for pancreatitis and pancreatic cancer.
Pancreatic Cancer Application Provides First Toehold for Biological Dynamics in Clinical Testing
Premium
The company is validating early promising data for an exosomal-protein based signature to identify asymptomatic individuals with early pancreatic cancer.
Immunovia, JW BioScience Ink Licensing Agreement for Early Pancreatic Cancer Detection Biomarkers
Immunovia said that it has secured intellectual property rights to the biomarkers, which are part of the diagnostic signature for its Immray PanCan-d blood test.
Konica Minolta Joins Precede Consortium to Improve Diagnosis and Treatment of Pancreatic Cancer
The company will employ its Lattice platform to shepherd and translate genomic and other data toward the development of new early diagnostics and interventions.
Bluestar Genomics Raises $70M in Series C Funding Round
The San Diego-based early cancer detection firm has also appointed Felix Fang and Craig Venter to its scientific advisory board.